PURPOSE: To investigate the clinicopathologic significance and predictive value of Bmi-1 expression in patients with colon cancer. METHODS: Bmi-1 expression was assessed by immunohistochemistry, PCR, and western blotting in specimens from 203 patients and by immunohistochemistry in 66 specimens of lymph node metastasis (LNM). RESULTS: Positive staining of Bmi-1 occurred in 7.9% (16/203), 66.5% (135/203), and 86.4% (57/66) of specimens from normal tissue, colon cancer, and LNM, respectively. Staining was significantly correlated with clinical stage, depth of invasion, nodal involvement, distant metastasis, and Ki67 level. Bmi-1 was upregulated at the transcriptional and translational levels. Patients with Bmi-1-positive localized tumors had a much lower 5-year disease-free survival (relative risk 2.919, P < 0.0001) and overall survival (relative risk 5.056, P < 0.0001). Bmi-1 immunoreactivity emerged as an independent prognostic factor in the multivariate analysis. CONCLUSIONS: We have shown that expression of Bmi-1 was elevated in colon cancer and might serve as an independent prognostic marker.
PURPOSE: To investigate the clinicopathologic significance and predictive value of Bmi-1 expression in patients with colon cancer. METHODS:Bmi-1 expression was assessed by immunohistochemistry, PCR, and western blotting in specimens from 203 patients and by immunohistochemistry in 66 specimens of lymph node metastasis (LNM). RESULTS: Positive staining of Bmi-1 occurred in 7.9% (16/203), 66.5% (135/203), and 86.4% (57/66) of specimens from normal tissue, colon cancer, and LNM, respectively. Staining was significantly correlated with clinical stage, depth of invasion, nodal involvement, distant metastasis, and Ki67 level. Bmi-1 was upregulated at the transcriptional and translational levels. Patients with Bmi-1-positive localized tumors had a much lower 5-year disease-free survival (relative risk 2.919, P < 0.0001) and overall survival (relative risk 5.056, P < 0.0001). Bmi-1 immunoreactivity emerged as an independent prognostic factor in the multivariate analysis. CONCLUSIONS: We have shown that expression of Bmi-1 was elevated in colon cancer and might serve as an independent prognostic marker.
Authors: Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha Journal: Cancer Res Date: 2006-06-15 Impact factor: 12.701
Authors: Tatiana V Petrova; Antti Nykänen; Camilla Norrmén; Konstantin I Ivanov; Leif C Andersson; Caj Haglund; Pauli Puolakkainen; Frank Wempe; Harald von Melchner; Gérard Gradwohl; Sakari Vanharanta; Lauri A Aaltonen; Juha Saharinen; Massimiliano Gentile; Alan Clarke; Jussi Taipale; Guillermo Oliver; Kari Alitalo Journal: Cancer Cell Date: 2008-05 Impact factor: 31.743
Authors: Shu Zhang; Curt Balch; Michael W Chan; Hung-Cheng Lai; Daniela Matei; Jeanne M Schilder; Pearlly S Yan; Tim H-M Huang; Kenneth P Nephew Journal: Cancer Res Date: 2008-06-01 Impact factor: 12.701
Authors: Chaoyu Ma; Yu Rong; Daniel R Radiloff; Michael B Datto; Barbara Centeno; Shideng Bao; Anthony Wai Ming Cheng; Fumin Lin; Shibo Jiang; Timothy J Yeatman; Xiao-Fan Wang Journal: Genes Dev Date: 2008-02-01 Impact factor: 11.361
Authors: Katerina Vrzalikova; Joseph Skarda; Jiri Ehrmann; Paul G Murray; Eduard Fridman; Jury Kopolovic; Petra Knizetova; Marian Hajduch; Jiri Klein; Vitezslav Kolek; Lenka Radova; Zdenek Kolar Journal: J Cancer Res Clin Oncol Date: 2008-02-09 Impact factor: 4.553
Authors: Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum Journal: Proc Natl Acad Sci U S A Date: 2003-11-26 Impact factor: 11.205
Authors: Katrin Nowak; Kornelius Kerl; Daniel Fehr; Christoph Kramps; Christine Gessner; Katrin Killmer; Birgit Samans; Bernd Berwanger; Holger Christiansen; Werner Lutz Journal: Nucleic Acids Res Date: 2006-03-31 Impact factor: 16.971
Authors: Brij K Gupta; Diane M Maher; Mara C Ebeling; Phillip D Stephenson; Susan E Puumala; Michael R Koch; Hiroyuki Aburatani; Meena Jaggi; Subhash C Chauhan Journal: J Gastroenterol Date: 2013-10-07 Impact factor: 7.527
Authors: Xinqi He; Yujuan Dong; Chung Wah Wu; Zengren Zhao; Simon S M Ng; Francis K L Chan; Joseph J Y Sung; Jun Yu Journal: Mol Med Date: 2013-02-08 Impact factor: 6.354
Authors: Antonija Kreso; Peter van Galen; Nicholas M Pedley; Evelyne Lima-Fernandes; Catherine Frelin; Thomas Davis; Liangxian Cao; Ramil Baiazitov; Wu Du; Nadiya Sydorenko; Young-Choon Moon; Lianne Gibson; Yadong Wang; Cherry Leung; Norman N Iscove; Cheryl H Arrowsmith; Eva Szentgyorgyi; Steven Gallinger; John E Dick; Catherine A O'Brien Journal: Nat Med Date: 2013-12-01 Impact factor: 53.440